A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...
The once-daily oral drug, a SARS-CoV-2 main protease inhibitor developed by Shionogi, is registered in Japan and Singapore ...
AI may help radiologists evaluate mammograms for breast cancer more effectively, but researchers at UCLA, UC Davis and ...
Eliminating breast surgery for triple negative or HR-/HER2+ breast cancer patients with clinical complete response to combined neoadjuvant chemotherapy and neoadjuvant radiotherapy: A multicenter, ...
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial In this global phase III ...
A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...
Cretostimogene grenadenorepvec, an oncolytic immunotherapy, selectively replicates in and lyses cancer cells with Rb-E2F pathway alterations, releasing antigens that initiate antitumor immune ...
A large-scale randomized trial of texting therapy concluded that its outcomes were as good as video sessions in treating ...
OPN equals IVL in efficacy and safety. The VICTORY trial demonstrates non-inferiority in complex and calcified coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback